| PCVX Stock | | | USD 88.54 0.15 0.17% |
Vaxcyte financial indicator trend analysis is much more than just breaking down Vaxcyte prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Vaxcyte is a good investment. Please check the relationship between Vaxcyte Current Deferred Revenue and its Common Stock Total Equity accounts. Check out
Your Equity Center to better understand how to build diversified portfolios, which includes a position in Vaxcyte. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in real.
For more information on how to buy Vaxcyte Stock please use our
How to Invest in Vaxcyte guide.
Current Deferred Revenue vs Common Stock Total Equity
Current Deferred Revenue vs Common Stock Total Equity Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Vaxcyte Current Deferred Revenue account and
Common Stock Total Equity. At this time, the significance of the direction appears to have pay attention.
The correlation between Vaxcyte's Current Deferred Revenue and Common Stock Total Equity is -0.84. Overlapping area represents the amount of variation of Current Deferred Revenue that can explain the historical movement of Common Stock Total Equity in the same time period over historical financial statements of Vaxcyte, assuming nothing else is changed. The correlation between historical values of Vaxcyte's Current Deferred Revenue and Common Stock Total Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Current Deferred Revenue of Vaxcyte are associated (or correlated) with its Common Stock Total Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock Total Equity has no effect on the direction of Current Deferred Revenue i.e., Vaxcyte's Current Deferred Revenue and Common Stock Total Equity go up and down completely randomly.
Correlation Coefficient | -0.84 |
| Relationship Direction | Negative |
| Relationship Strength | Significant |
Current Deferred Revenue
Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.
Common Stock Total Equity
The total value of common stock equity held by shareholders, representing their ownership interest in the company.
Most indicators from Vaxcyte's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Vaxcyte current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Your Equity Center to better understand how to build diversified portfolios, which includes a position in Vaxcyte. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in real.
For more information on how to buy Vaxcyte Stock please use our
How to Invest in Vaxcyte guide.
Selling General Administrative is likely to rise to about 63.7
M in 2024, whereas
Issuance Of Capital Stock is likely to drop slightly above 364.6
M in 2024.
Vaxcyte fundamental ratios Correlations
Click cells to compare fundamentals
Vaxcyte Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Vaxcyte fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Vaxcyte Stock Analysis
When running Vaxcyte's price analysis, check to
measure Vaxcyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxcyte is operating at the current time. Most of Vaxcyte's value examination focuses on studying past and present price action to
predict the probability of Vaxcyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxcyte's price. Additionally, you may evaluate how the addition of Vaxcyte to your portfolios can decrease your overall portfolio volatility.